Urolithin A, Catalog: B1155

IN STOCK!
US$0.00

3,8-Hydroxydibenzo-α-pyrone; 3,8-Dihydroxyurolithin; 2’,7-Dihydroxy-3,4-benzocoumarin; δ-Lactone 2’,4,4’-Trihydroxy-2-biphenylcarboxylic Acid

PRODUCT SUMMARY

Alternate Names 3,8-Hydroxydibenzo-α-pyrone; 3,8-Dihydroxyurolithin; 2’,7-Dihydroxy-3,4-benzocoumarin; δ-Lactone 2’,4,4’-Trihydroxy-2-biphenylcarboxylic Acid

Appearance Brown Solid

CAS # 1143-70-0

Molecular Formula C₁₃H₈O₄

Molecular Weight 228.2

Purity ≥ 98% by HPLC

Solubility DMSO (5 mg/ml)

SMILES C1=CC2=C(C=C1O)C(=O)OC3=C2C=CC(=C3)O

InChi 1S/C13H8O4/c14-7-1-3-9-10-4-2-8(15)6-12(10)17-13(16)11(9)5-7/h1-6,14-15H

InChi Key RIUPLDUFZCXCHM-UHFFFAOYSA-N

PubChem CID 5488186

Storage Conditions -20°C

Shipping Conditions Gel Pack

Usage For Research Use Only! Not For Use in Humans.

Handling Do not take it internally. Wear a glove and mask when handling the product. Protect from air and moisture.

DESCRIPTION

Urolithin A is generated by gut microflora as a natural metabolite of ellagitannins, a class of compounds found in the pomegranate and other fruits and nuts. Oral administration of urolithin A leads to an improved mitochondrial function by stimulating mitophagy